Ospedale Sacro Cuore di Gesù - FATEBENEFRATELLI

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
CAPRI 2 GOIM Study: Investigate the Efficacy and Safety of a Bio-marker Driven Cetuximab-based Treatment Regimen	Metastatic Colorectal Adenocarcinoma	Active, not recruiting	Phase 2	2025-05-25		NCT05312398

Clinical trials